Pathological Investigation on RNF213: Animal Models Knockout and Transgenic Mice in Diabetes and Signal Transduction-Reference-Cited by-同舟云学术

Pathological Investigation on RNF213: Animal Models Knockout and Transgenic Mice in Diabetes and Signal Transduction

Published:2017 Issue: Volume: Page:69-78
ISSN:2364-8333
Container-title:Current Topics in Environmental Health and Preventive Medicine
language:
Short-container-title:

Author:

Kobayashi Hatasu

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-10-2711-6_6

Reference29 articles.

1. Koizumi A. Genetic analysis of familial moyamoya. Annual report of the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) by Science Research Grants of Ministry of Health, Labor and Welfare, Japan (Chaired by N. Hashimoto); 2010.

2. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34–40. doi:jhg2010132 [pii] 1038/jhg.2010.132.

3. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PloS one. 2011;6(7):e22542. doi:10.1371/journal.pone.0022542 PONE-D-10-04031 [pii].

4. Morito D, Nishikawa K, Hoseki J, Kitamura A, Kotani Y, Kiso K, et al. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep. 2014;4:4442. doi: 10.1038/srep04442 .

5. Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med. 2015; doi: 10.1007/s12199-015-0498-7 .